Armata Pharmaceuticals has posted early validation of its phage platform. The phase 1b/2a trial linked a bacteriophage ...

Cat1 – which can deplete a metabolite essential for cellular function. Left without fuel, Cat1 helps to stop invading viruses ...

The discovery of Cat1 reveals how CARF effectors use complex structures to inhibit viral replication, advancing our ...

Newly discovered weapons of bacterial self-defense take different approaches to achieving the same goal: preventing a virus from spreading through the bacterial population.

clinical – of mixing therapeutic phages into cocktails consisting of multiple virus types. We conclude with a discussion of the commercial and medical context of phage cocktails as therapeutic ...

Usually, when a virus infects a cell by itself ... tools to study it in more detail than ever before. “The field of phage biology has seen an explosion over the last decade because more ...

Psychological barriers to phage acceptance remain. “Some people worry about getting treated with a virus,” Merril says, “but they don’t realize that many of today’s leading vaccines are ...

When a virus infects the bacteria ... One promising alternative is phage therapy—the use of viruses that specifically infect and kill unwanted bacteria. But bacteria aren't defenseless; they ...

Although it is well established that host cells provide metabolic resources for virus replication ... into particulate biomass indicate that phage infection redirects ∼75% of nutrients into ...

A bacteriophage is a type of virus that infects bacteria. In fact, the word "bacteriophage" literally means "bacteria eater," because bacteriophages destroy their host cells. All bacteriophages ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...